Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Germano Di Sciascio

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
Fundamental & Clinical Pharmacology|November 16, 2007
The ARMYDA trials (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) at Campus Bio-Medico University: rationale, results and future horizonsGermano di Sciascio
Giornale Italiano Di Cardiologia (2006)|November 9, 2006
[Echocardiography in patent foramen ovale]Addolorata Carcagnì, Germano Di Sciascio
Giornale Italiano Di Cardiologia (2006)|March 15, 2006
[Transcatheter cell therapy of heart failure: state of the art]Andrea D'Ambrosio, Germano Di Sciascio
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 12, 2009
Antithrombotic strategies in patients on oral anticoagulant therapy undergoing percutaneous coronary intervention: a proposed algorithm based on individual risk stratificationGiuseppe Patti, Germano Di Sciascio
Internal and Emergency Medicine|January 9, 2009
Contemporary issues on clopidogrel therapyGiuseppe Patti, Germano Di Sciascio
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 23, 2018
P2Y12 inhibition in STEMI: early, strong or both?Fabio Mangiacapra, Germano Di Sciascio
Journal of the American College of Cardiology|June 12, 2012
Platelet reactivity and percutaneous coronary intervention: another clue in the quest for the Holy Grail of tailored antithrombotic therapy?Germano Di Sciascio, Fabio Mangiacapra
Cardiovascular & Hematological Disorders Drug Targets|June 22, 2006
Prevention of myocardial damage during coronary interventionVincenzo Pasceri, Giuseppe Patti, Germano Di Sciascio
JAMA|June 23, 2011
Standard- vs high-dose clopidogrel after percutaneous coronary interventionGiuseppe Patti, Vincenzo Pasceri, Germano Di Sciascio
The American Journal of Cardiology|November 11, 2008
Meta-analysis comparison (nine trials) of outcomes with drug-eluting stents versus bare metal stents in patients with diabetes mellitusGiuseppe Patti, Annunziata Nusca, Germano Di Sciascio
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
Fundamental & Clinical Pharmacology|November 16, 2007
The ARMYDA trials (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) at Campus Bio-Medico University: rationale, results and future horizonsGermano di Sciascio
Giornale Italiano Di Cardiologia (2006)|November 9, 2006
[Echocardiography in patent foramen ovale]Addolorata Carcagnì, Germano Di Sciascio
Giornale Italiano Di Cardiologia (2006)|March 15, 2006
[Transcatheter cell therapy of heart failure: state of the art]Andrea D'Ambrosio, Germano Di Sciascio
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 12, 2009
Antithrombotic strategies in patients on oral anticoagulant therapy undergoing percutaneous coronary intervention: a proposed algorithm based on individual risk stratificationGiuseppe Patti, Germano Di Sciascio
Internal and Emergency Medicine|January 9, 2009
Contemporary issues on clopidogrel therapyGiuseppe Patti, Germano Di Sciascio
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 23, 2018
P2Y12 inhibition in STEMI: early, strong or both?Fabio Mangiacapra, Germano Di Sciascio
Journal of the American College of Cardiology|June 12, 2012
Platelet reactivity and percutaneous coronary intervention: another clue in the quest for the Holy Grail of tailored antithrombotic therapy?Germano Di Sciascio, Fabio Mangiacapra
Cardiovascular & Hematological Disorders Drug Targets|June 22, 2006
Prevention of myocardial damage during coronary interventionVincenzo Pasceri, Giuseppe Patti, Germano Di Sciascio
JAMA|June 23, 2011
Standard- vs high-dose clopidogrel after percutaneous coronary interventionGiuseppe Patti, Vincenzo Pasceri, Germano Di Sciascio
The American Journal of Cardiology|November 11, 2008
Meta-analysis comparison (nine trials) of outcomes with drug-eluting stents versus bare metal stents in patients with diabetes mellitusGiuseppe Patti, Annunziata Nusca, Germano Di Sciascio
Pageof 15